Neurocognitive impairment and psychiatric comorbidity in well-controlled human immunodeficiency virus–infected Thais from the 2NN Cohort Study

Updated research nosology for HIV-associated neurocognitive disorders

Andrea Antinori, Gabriele Arendt, James T. Becker et al. · Neurology · 2007 · 2.6K citations

Medicine, Neurology, Neuroscience +14

Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous System

Scott Letendre · Archives of Neurology · 2008 · 828 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

Frank van Leth, Praphan Phanuphak, Kiat Ruxrungtham et al. · The Lancet · 2004 · 683 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

The prevalence and incidence of neurocognitive impairment in the HAART era

Kevin R. Robertson, Marlene Smurzynski, Thomas D. Parsons et al. · AIDS · 2007 · 625 citations

Medicine, Immunology, Neurology +16

HIV-associated cognitive impairment before and after the advent of combination therapy

Ned Sacktor, Michael McDermott, Karen Marder et al. · Journal of NeuroVirology · 2002 · 592 citations · Full text

Medicine, Neurology, Pharmacotherapy +14